Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 7, 2007 - Issue 5
Submit an article Journal homepage
79
Views
11
CrossRef citations to date
0
Altmetric
Special Report

Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder

Rogier M Klok Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1 9713 AV Groningen, The Netherlands
,
Asmar FY Al Hadithy Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1 9713 AV Groningen, The Netherlands
,
Nathalie PJT van Schayk AstraZeneca BV, PO Box 599, 2700 AN, Zoetermeer, The Netherlands
,
Ad JJ Antonisse AstraZeneca BV, PO Box 599, 2700 AN, Zoetermeer, The Netherlands
,
Jaime J Caro Caro Research Institute, 336 Baker Ave., Concord, MA 01742, USA
,
Jacobus RBJ Brouwers Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1 9713 AV Groningen, The Netherlands
&
Maarten J Postma Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1 9713 AV Groningen, The Netherlands. [email protected]
 show all
Pages 459-467 | Published online: 09 Jan 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Laura Sawyer, Jean-Michel Azorin, Stacey Chang, Claudia Rinciog, Alice Guiraud-Diawara, Caroline Marre & Karina Hansen. (2014) Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes. Journal of Medical Economics 17:7, pages 508-519.
Read now

Articles from other publishers (10)

Syaribah N. Brice, Paul R. Harper, Daniel Gartner & Doris A. Behrens. (2023) Modeling disease progression and treatment pathways for depression jointly using agent based modeling and system dynamics. Frontiers in Public Health 10.
Crossref
James Altunkaya, Jung-Seok Lee, Apostolos Tsiachristas, Felicity Waite, Daniel Freeman & José Leal. (2021) Appraisal of patient-level health economic models of severe mental illness: systematic review. The British Journal of Psychiatry 220:2, pages 86-97.
Crossref
Ifigeneia Mavranezouli & Joran Lokkerbol. (2016) A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. PharmacoEconomics 35:3, pages 271-296.
Crossref
Ana Flávia Barros da Silva Lima, Luciane Cruz, Mírian Cohen, Jacques José Zimmermann & Sandro René Pinto de Sousa Miguel. 2017. Mental Health Economics. Mental Health Economics 299 311 .
Terence A. Ketter, Shefali Miller, Bernardo Dell’Osso & Po W. Wang. (2016) Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium. Journal of Affective Disorders 191, pages 256-273.
Crossref
Anees Ahmed Abdul Pari, Judit Simon, Jane Wolstenholme, John R Geddes & Guy M Goodwin. (2014) Economic evaluations in bipolar disorder: a systematic review and critical appraisal. Bipolar Disorders 16:6, pages 557-582.
Crossref
Syed Mohiuddin. (2014) A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder. Applied Health Economics and Health Policy 12:4, pages 359-372.
Crossref
Chiara Caresano, Guido Di Sciascio, Andrea Fagiolini, Giuseppe Maina, Giulio Perugi, Claudio Ripellino & Claudio Vampini. (2014) Cost-Effectiveness of Asenapine in the Treatment of Patients with Bipolar I Disorder with Mixed Episodes in an Italian Context. Advances in Therapy 31:8, pages 873-890.
Crossref
Jonathan Karnon & Hossein Haji Ali Afzali. (2014) When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES. PharmacoEconomics 32:6, pages 547-558.
Crossref
R. Sabes‐Figuera, D. Razzouk & Paul E. McCrone. 2010. Bipolar Disorder. Bipolar Disorder 90 95 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.